FDA Revised EUA for Paxlovid to Authorize Prescription

FDA says it has revised the Emergency Use Authorization for Pfizer’s Paxlovid, to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients with certain limitations.

• “Since Paxlovid must be taken within five days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment for some patients who are eligible to receive this drug for the treatment of COVID-19,”Patrizia Cavazzoni, director for the FDA’s Center for Drug Evaluation and Research said
• Note: Pfizer Seeks FDA Approval for Paxlovid in High-Risk Patients

NOTE

• Pfizer Inc. rose 0.9% to $52.11 as of 12:39 p.m. New York time ...